Kailey Temple
Family · Waterford, MINPI 1427552587
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,606 of the $13,696 with a category attached, or 70.1%. 31 manufacturers reported payments, led by Incyte Corporation at 24.4% of the total. Reporting peaked in 2023 at $6,440 and has fallen 73.0% since, to $1,741 in 2025. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 500 payments — averaging $27.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$3K
- Sanofi$1K
- AbbVie$1K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$936
- Regeneron Healthcare Solutions, Inc.$930
- plus $5K from 25 others
What the payments were for
- Consulting fees$2,53819%
- Speaking & faculty fees$540%
- Travel & lodging$7245%
- Food & beverage$9,60670%
- Education$7746%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 23 | $3,347 |
| Sanofi | 38 | $1,326 |
| AbbVie | 77 | $1,286 |
| Johnson & Johnson | 48 | $1,113 |
| Sun Pharmaceutical Industries Inc. | 30 | $936 |
| Regeneron Healthcare Solutions, Inc. | 34 | $930 |
| Novartis | 46 | $819 |
| LEO Pharma Inc. | 47 | $651 |
| E.r. Squibb & Sons, L.L.C. | 17 | $382 |
| Lilly USA, LLC | 20 | $362 |
| UCB, Inc. | 14 | $355 |
| Pfizer | 17 | $342 |
| Amgen | 13 | $245 |
| Dermavant Sciences, Inc. | 13 | $244 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $197 |
| Janssen Scientific Affairs, LLC | 3 | $188 |
| Boehringer Ingelheim | 5 | $126 |
| Arcutis Biotherapeutics, Inc. | 7 | $124 |
| Genentech USA, Inc. | 6 | $117 |
| Galderma Laboratories, L.p. | 7 | $113 |
| Verrica Pharmaceuticals Inc. | 5 | $94 |
| Almirall LLC | 4 | $72 |
| Journey Medical Corporation | 3 | $65 |
| Organon | 3 | $64 |
| Mayne Pharma Commercial LLC | 3 | $44 |
| AstraZeneca | 2 | $39 |
| Smith+Nephew | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| EPI Health, LLC | 1 | $19 |
| Biofrontera Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,696 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 60 | $224,835 |
| RinvoqUpadacitinib | 25 | $161,191 |
| Ketoconazole | 97 | $1,667 |
| Clobetasol Propionate | 30 | $1,567 |
| Tacrolimus | 13 | $1,411 |
| Mometasone Furoate | 63 | $1,191 |
| Montelukast Sodium | 108 | $956 |
| Triamcinolone Acetonide | 53 | $912 |
| Ammonium Lactate | 43 | $807 |
| Ciclopirox | 12 | $674 |
| Metronidazole | 15 | $603 |
| Imiquimod | 12 | $513 |
| Clindamycin Phosphate | 18 | $498 |
| Fluticasone Propionate | 19 | $428 |
| Finasteride | 40 | $378 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $1,286 | $161,19125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Waterford
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.